subject: UMLS:C1512474

subject_name: Histone deacetylase inhibitor


subject: UMLS:C1512474

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified

tested_intervention: unsure


subject: UMLS:C3537120

subject_name: Histone Deacetylase Inhibitor [EPC]

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C3537120


subject: CHEBI:172786

object_name: Cardiovascular Risk


subject: CHEBI:172786

object_name: Menopause related conditions


subject: CHEBI:4775

subject_name: Ellagic acid


subject: CHEBI:4775


subject: CHEBI:18220

subject_name: Isoflavone


subject: CHEBI:87631

subject_name: statin

object_name: delirium


subject: CHEBI:87631

object_name: Delirium, CTCAE


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: UMLS:C0001645


subject: CHEBI:231324

subject_name: alpelisib

object_name: PTEN Positive


subject: CHEBI:231324

object_name: Androgen Receptor Positive


subject: CHEBI:231324

object_name: Metastatic Breast Carcinoma


subject: CHEBI:231324

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:231324

object_name: HER2/Neu Negative


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534


subject: CHEBI:68534


subject: CHEBI:68534

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:68534


subject: CHEBI:68534

object_name: Breast cancer recurrent


subject: CHEBI:68534

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:68534

object_name: Advanced Breast Carcinoma


subject: CHEBI:68534

object_name: Refractory Breast Carcinoma


subject: CHEBI:68534


subject: UNII:7N13IK9LNH

object_name: Advanced Ovarian Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Pancreatic Adenocarcinoma


subject: UNII:7N13IK9LNH

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Ovarian Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:7N13IK9LNH

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Fallopian Tube Carcinoma


subject: UNII:7N13IK9LNH

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Advanced Primary Peritoneal Carcinoma


subject: UNII:7N13IK9LNH

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: high grade ovarian serous adenocarcinoma


subject: UNII:7N13IK9LNH

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:7N13IK9LNH

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:7N13IK9LNH

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:7N13IK9LNH

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: DRUGBANK:DB19041

subject_name: Elimusertib

object_name: Advanced Ovarian Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Pancreatic Adenocarcinoma


subject: DRUGBANK:DB19041

object_name: Stage IV Ovarian Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Ovarian Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage II Pancreatic Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Advanced Malignant Solid Neoplasm


subject: DRUGBANK:DB19041

object_name: Platinum-Resistant Ovarian Carcinoma


subject: DRUGBANK:DB19041

object_name: Advanced Fallopian Tube Carcinoma


subject: DRUGBANK:DB19041

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Advanced Primary Peritoneal Carcinoma


subject: DRUGBANK:DB19041

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: high grade ovarian serous adenocarcinoma


subject: DRUGBANK:DB19041

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: DRUGBANK:DB19041

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: DRUGBANK:DB19041

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: DRUGBANK:DB19041

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:175901

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:175901

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UMLS:C4733613

subject_name: SLCT Inhibitor GNS561

object_name: cholangiocarcinoma


subject: CHEBI:50885

subject_name: Fludrocortisone

object_name: congenital adrenal hyperplasia


subject: CHEBI:5132

subject_name: Flutamide


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:9460

subject_name: Testolactone


subject: UMLS:C5854465

subject_name: Anti-FRa Antibody-drug Conjugate AZD5335

object_name: ovarian cancer


subject: UMLS:C5854465

object_name: ovarian neoplasm


subject: UMLS:C5854465

object_name: endometrial cancer


subject: UMLS:C5854465

object_name: uterine corpus cancer


subject: UMLS:C5854465

object_name: endometrial carcinoma


subject: UMLS:C5854465

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: UMLS:C5706468

subject_name: PARP1 Inhibitor AZD9574


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: DRUGBANK:DB18982

subject_name: Saruparib


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: GTOPDB:11827

subject_name: telitacicept

object_name: Nephrotic syndrome in children


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Postoperative infection


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:231324

subject_name: alpelisib

object_name: Her2-receptor negative breast cancer


subject: UNII:2EWN8Z05CN

subject_name: Zotatifin


subject: UNII:2EWN8Z05CN

object_name: Childhood Breast Carcinoma


subject: UNII:2EWN8Z05CN

object_name: breast carcinoma


subject: UNII:2EWN8Z05CN

object_name: breast cancer


subject: UNII:2EWN8Z05CN

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: coronary artery disorder

tested_intervention: yes


subject: CHEBI:45863

object_name: coronary atherosclerosis


subject: CHEBI:45863

object_name: Angina pectoris


subject: CHEBI:194135

subject_name: Ofloxacin

object_name: Reiter Syndrome


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:48935

subject_name: roxithromycin


subject: CHEBI:32109

subject_name: (Z)-roxithromycin


subject: CHEBI:8382

subject_name: Prednisone

object_name: Restless legs


subject: GTOPDB:12990

subject_name: sintilimab

object_name: childhood malignant neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Subfertility


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:91951

object_name: Locally advanced breast cancer


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:6741

subject_name: Meloxicam

object_name: Postoperative Pain, Acute


subject: CHEBI:6741

object_name: skin neoplasm


subject: CHEBI:6741

object_name: skin cancer


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: melanoma


subject: CHEBI:73604

object_name: skin melanoma


subject: CHEBI:73604

object_name: mucosal melanoma


subject: UMLS:C4548795

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Myalgia


subject: CHEBI:15377

subject_name: Water


subject: UNII:KXQ762CQTH

object_name: triple-negative breast carcinoma


subject: UNII:KXQ762CQTH

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UMLS:C0114857

subject_name: Dotarem

object_name: peripheral vascular disease


subject: UMLS:C0114857

object_name: peripheral arterial disease


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Clinical Partial Response


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UNII:MQ5GV2WUK4

subject_name: LERAPOLTUREV

object_name: Recurrent Supratentorial Glioblastoma


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Peptic Ulcer Hemorrhage


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Loss of Chromosome 17p


subject: CHEBI:133021

object_name: chromosome 17p deletion


subject: CHEBI:94366

subject_name: itraconazole

object_name: hepatitis C


subject: CHEBI:94366

object_name: chronic hepatitis C virus infection


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Blood Pressure Finding


subject: CHEBI:6129

object_name: Systemic arterial pressure


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: end stage renal failure


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C4305825

object_name: Finding of corneal transplant


subject: UMLS:C4305825

object_name: corneal disease


subject: CHEBI:90930

subject_name: Aripiprazole lauroxil

object_name: schizoaffective disorder


subject: CHEBI:90930

object_name: schizophrenia 18


subject: CHEBI:31355

subject_name: Carboplatin

object_name: benign urinary system neoplasm


subject: CHEBI:31355

object_name: urinary system neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C5854377

subject_name: TTK/PLK1 Inhibitor BAL0891

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854377

object_name: adult acute myeloid leukemia


subject: UMLS:C5854377

object_name: Leukemia - acute myeloid leukemia (AML)


subject: UMLS:C5854377

object_name: childhood acute myeloid leukemia


subject: UMLS:C5854377

object_name: acute myeloid leukemia


subject: UMLS:C5854377

object_name: triple-negative breast carcinoma


subject: UMLS:C5854377

object_name: Stomach cancer


subject: UMLS:C5854377

object_name: gastric cancer


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: DRUGBANK:DB16564

subject_name: Mucopolysaccharide polysulphate

object_name: thrombocytopenia


subject: DRUGBANK:DB16564

object_name: hematologic disorder


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Metastatic Triple-Negative Breast Inflammatory Carcinoma


subject: CHEBI:70839

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester


subject: PUBCHEM.COMPOUND:3298


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: UMLS:C5203926

subject_name: EZH2 Inhibitor SHR2554

object_name: follicular lymphoma


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: pancreatic adenocarcinoma


subject: UMLS:C2828372


subject: UMLS:C0064294

subject_name: fibroblast growth factor 7

object_name: alopecia


subject: UMLS:C0064294

object_name: Alopecia, CTCAE


subject: UMLS:C0064294

object_name: Chemotherapy-induced change


subject: UMLS:C0064294

object_name: alopecia drugs


subject: UMLS:C5203417

subject_name: Cefazolin Liquid Injection

object_name: Childhood Breast Carcinoma


subject: UMLS:C5203417

object_name: breast carcinoma


subject: UMLS:C5203417

object_name: breast cancer


subject: CHEBI:474053

subject_name: Cefazolin


subject: CHEBI:474053


subject: CHEBI:474053


subject: UMLS:C4279748

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether

object_name: neurofibromatosis 1


subject: PUBCHEM.COMPOUND:2724258

object_name: neurofibromatosis type 1


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459


subject: CHEBI:5312

subject_name: gentamicin sulfate

object_name: Stress urinary incontinence


subject: CHEBI:5312

object_name: pelvic organ prolapse


subject: CHEBI:5312

object_name: Postoperative urinary tract infection


subject: UNII:8X7386QRLV

subject_name: GENTAMICIN SULFATE


subject: UNII:8X7386QRLV


subject: UNII:8X7386QRLV


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:2735

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C2347419

object_name: ovarian cancer


subject: UMLS:C2347419

object_name: ovarian neoplasm


subject: UMLS:C2347419

object_name: ovarian carcinoma


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: primary ovarian failure


subject: CHEBI:38290

object_name: premature menopause


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:72296

subject_name: Apixaban

object_name: pancreatic neoplasm


subject: CHEBI:72296

object_name: exocrine pancreatic carcinoma


subject: CHEBI:72296

object_name: malignant pancreatic neoplasm


subject: CHEBI:72296

object_name: Deep thrombophlebitis


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: Chronic constipation


subject: UMLS:C0225326

subject_name: fiber


subject: UMLS:C1141002

subject_name: prune preparation


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: biliary tract cancer


subject: CHEBI:76842

object_name: CLABSI - central line associated bloodstream infection


subject: CHEBI:28001

subject_name: Vancomycin


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Diabetic foot ulcer


subject: UNII:T42P99266K

object_name: Diabetic wound


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: UMLS:C2981846

object_name: gastric neoplasm


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: Myeloblastic leukemia


subject: UMLS:C0694951

object_name: acute lymphoblastic leukemia


subject: UMLS:C0694951

object_name: lymphoid leukemia


subject: UMLS:C0694951

object_name: acute myelomonocytic leukemia M4


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:2682


subject: CHEBI:2682


subject: CHEBI:2682


subject: UNII:KE3U2023NP

subject_name: Poractant alfa

object_name: respiratory distress syndrome in premature infants


subject: UNII:KE3U2023NP

object_name: adult acute respiratory distress syndrome


subject: CHEBI:601027

subject_name: Aliskiren

object_name: cardiovascular disorder


subject: CHEBI:27791

subject_name: Diquafosol

object_name: dry eye syndrome


subject: CHEBI:27791

object_name: Computer vision syndrome


subject: CHEBI:27791

object_name: asthenopia


subject: CHEBI:85990

subject_name: Panobinostat

object_name: juvenile myelomonocytic leukemia


subject: UNII:D07V79Q44T

object_name: acute myeloid leukemia by FAB classification


subject: UNII:D07V79Q44T


subject: UNII:D07V79Q44T

object_name: chronic myelomonocytic leukemia


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Blood Loss


subject: CHEBI:9130

object_name: Hemorrhage


subject: UMLS:C3490884

object_name: acromegaly


subject: UMLS:C3490884

object_name: Acral overgrowth


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: MESH:D006896

subject_name: Hydroxyethylrutoside

object_name: Deep vein thrombosis of lower limb


subject: MESH:D006896

object_name: Deep venous thrombosis


subject: UMLS:C5203563

subject_name: Levocarnitine Liquid Injection

object_name: anemia


subject: UMLS:C5203563

object_name: Anemia, CTCAE


subject: UMLS:C5203563

object_name: end stage renal failure


subject: UMLS:C5203563

object_name: Chronic uremia


subject: UMLS:C5203563

object_name: kidney failure


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:16347


subject: CHEBI:5931

subject_name: insulin human

object_name: Poor glycemic control


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C5452874

subject_name: Glulisine


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:32696

object_name: chronic kidney disease


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: UMLS:C0054599

subject_name: canola oil


subject: UMLS:C0054599


subject: UMLS:C3473058

subject_name: Amyvid

object_name: Alzheimer Disease, Early Onset


subject: UMLS:C0114857

subject_name: Dotarem


subject: UMLS:C3864383

subject_name: Lumason


subject: UNII:800U03334F


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: steroid-resistant nephrotic syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: recurrent respiratory papillomatosis


subject: CHEBI:85994

object_name: Human Papilloma Virus, Female


subject: CHEBI:85994

object_name: Human Papilloma Virus, Male


subject: CHEBI:85994

object_name: lung disorder


subject: CHEBI:85994

object_name: History of - respiratory disease


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:53328043

subject_name: Iberdomide


subject: UMLS:C5555503

subject_name: Anti-CSF1R Monoclonal Antibody AMB-05X

object_name: tenosynovial giant cell tumor


subject: UMLS:C5555503

object_name: tenosynovial giant cell tumor, diffuse type


subject: UNII:DPT0O3T46P

object_name: Head and neck cancers - nasopharyngeal


subject: UNII:DPT0O3T46P

object_name: Head and neck cancers - salivary gland


subject: UNII:DPT0O3T46P

object_name: Head and neck cancers - tonsils


subject: UNII:DPT0O3T46P

object_name: Head and neck cancers - throat


subject: CHEMBL.COMPOUND:CHEMBL1743064

subject_name: ROBATUMUMAB

object_name: pediatric osteosarcoma


subject: CHEMBL.COMPOUND:CHEMBL1743064

object_name: Osteosarcoma


subject: CHEMBL.COMPOUND:CHEMBL1743064

object_name: Ewing sarcoma


subject: CHEMBL.COMPOUND:CHEMBL1743064

object_name: peripheral primitive neuroectodermal tumor


subject: UMLS:C3467798


subject: UMLS:C3467798


subject: UMLS:C3467798


subject: UMLS:C3467798


subject: CHEBI:125400

subject_name: actinomycin D

object_name: renal carcinoma


subject: CHEBI:125400

object_name: kidney neoplasm


subject: CHEBI:125400

object_name: kidney cancer


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:34373

subject_name: Gaboxadol

object_name: insomnia


subject: CHEBI:34373

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:34373

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: schizoaffective disorder


subject: CHEBI:53760

object_name: schizophrenia 18


subject: CHEBI:53760

object_name: sleep disorder


subject: PUBCHEM.COMPOUND:174735

subject_name: trimix

object_name: Malignant neoplasm of female breast


subject: PUBCHEM.COMPOUND:174735

object_name: Early Stage Breast Carcinoma


subject: UNII:HWQ5KFY3MU

subject_name: TRIMIX


subject: UNII:HWQ5KFY3MU


subject: UNII:JCU3O35RDS

subject_name: Sonlicromanol

object_name: MELAS syndrome


subject: UNII:JCU3O35RDS

object_name: inborn mitochondrial metabolism disorder


subject: UNII:JCU3O35RDS

object_name: mitochondrial disease


subject: UNII:JCU3O35RDS

object_name: Leber hereditary optic neuropathy


subject: UNII:JCU3O35RDS

object_name: Leigh syndrome


subject: UMLS:C5198795


subject: UMLS:C5198795


subject: UMLS:C5198795


subject: UMLS:C5198795


subject: UMLS:C5198795


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: Growth delay


subject: UMLS:C0002525

object_name: Failure to Thrive


subject: UMLS:C0002525

object_name: Nutritional stunting


subject: CHEBI:4893

subject_name: ethyl acetoacetate


subject: CHEBI:4893


subject: CHEBI:4893


subject: UMLS:C0243046

subject_name: Excitatory Amino Acids


subject: UMLS:C0243046


subject: UMLS:C0243046


subject: CHEBI:24433

subject_name: group


subject: CHEBI:24433


subject: CHEBI:24433


subject: DRUGBANK:DB18224

object_name: autosomal recessive congenital ichthyosis


subject: CHEBI:149509

object_name: essential hypertension, genetic


subject: CHEBI:149509

object_name: essential hypertension


subject: UNII:09OB3E5QTD

object_name: Advanced cancer


subject: UMLS:C3886555


subject: UMLS:C3658170

object_name: poikiloderma with neutropenia


subject: UMLS:C3658170

object_name: prurigo nodularis


subject: UNII:N5UK68MGDZ

subject_name: Apremilast


subject: UNII:N5UK68MGDZ


subject: CHEBI:3655

subject_name: Chlorzoxazone

object_name: Post-Operative Pain


subject: UMLS:C1831847

subject_name: Live Freeze-Dried Lactic Acid Bacteria Probiotic

object_name: liver cirrhosis


subject: UMLS:C1831847

object_name: portal hypertension


subject: UMLS:C1831847

object_name: Portal Hypertension, CTCAE


subject: UMLS:C1831847

object_name: Encephalopathy Related to COVID-19


subject: UMLS:C1831847

object_name: brain disorder


subject: UMLS:C1831847

object_name: Encephalopathy, CTCAE 5.0


subject: UMLS:C1831847

object_name: Encephalopathy, CTCAE 3.0


subject: CHEBI:6121

subject_name: Ketamine

object_name: conscious sedation failure during procedure


subject: CHEBI:44915

subject_name: Propofol


subject: UMLS:C5207033

subject_name: NanoPac

object_name: prostate adenocarcinoma


subject: UMLS:C5207033

object_name: Localized Malignant Neoplasm


subject: UMLS:C5207033

object_name: prostate neoplasm


subject: UMLS:C5207033

object_name: male reproductive system neoplasm


subject: UMLS:C5207033

object_name: male reproductive organ cancer


subject: UMLS:C5207033

object_name: Neoplasm of the genitourinary tract


subject: UMLS:C5206814

subject_name: Submicron Particle Paclitaxel Sterile Suspension


subject: UMLS:C5206814


subject: UMLS:C5206814


subject: UMLS:C5206814


subject: UMLS:C5206814


subject: UMLS:C5206814


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: cervical polyp


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:8774

subject_name: Ramipril


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: atopic eczema


subject: RXCUI:8375

object_name: psoriasis


subject: UNII:HXH71NRQ5C

object_name: perinatal asphyxia


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: systolic heart failure


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: INTRA-UTERINE DEVICE COMPLICATION


subject: CHEBI:50777

object_name: mucositis


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: hypoparathyroidism


subject: PUBCHEM.COMPOUND:6096882

object_name: Hypoparathyroidism, CTCAE


subject: PUBCHEM.COMPOUND:6096882

object_name: Pathologic Neovascularization


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:63V8AIE65T

object_name: brain neoplasm


subject: UNII:63V8AIE65T

object_name: metastatic malignant neoplasm in the brain


subject: UNII:63V8AIE65T

object_name: medulloblastoma


subject: UNII:63V8AIE65T

object_name: childhood medulloblastoma


subject: UNII:63V8AIE65T

object_name: adult medulloblastoma


subject: UMLS:C4087030

object_name: Seizure Related to COVID-19


subject: UMLS:C4087030

object_name: visual epilepsy


subject: UMLS:C4087030

object_name: tuberous sclerosis


subject: UMLS:C4087030

object_name: situs inversus


subject: UMLS:C4087030

object_name: tuberous sclerosis 1


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: Acute pulmonary embolism


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: endometrial disorder


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C4724880

object_name: paroxysmal nocturnal hemoglobinuria


subject: PUBCHEM.COMPOUND:73755261

subject_name: acelarin

object_name: familial pancreatic carcinoma


subject: PUBCHEM.COMPOUND:73755261

object_name: pancreatic neoplasm


subject: UNII:XCL1K2T28K


subject: UNII:XCL1K2T28K


subject: UMLS:C3896724

subject_name: Acelarin


subject: UMLS:C3896724


subject: CHEBI:8774

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:8774

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:8774

object_name: morbid obesity


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Muscle Atrophy


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:9150

subject_name: Simvastatin

object_name: cerebral cavernous malformation


subject: CHEBI:9150

object_name: cerebral cavernous malformation 1


subject: CHEBI:9150

object_name: famililal cerebral cavernous malformations


subject: CHEBI:9150

object_name: Cerebral Cavernous Hemangioma


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: immune system disorder


subject: DRUGBANK:DB14239

subject_name: Echinacea purpurea


subject: CHEBI:78236

subject_name: N-acetyl-L-cysteinate


subject: UNII:2SPH1IMO2V

subject_name: N-Acetyl-D-cysteine


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:71464

subject_name: Palmidrol


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Mixed vascular malformation


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Indolent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Indolent lymphoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: sinusitis


subject: PUBCHEM.COMPOUND:3467

object_name: Sinusitis, CTCAE


subject: PUBCHEM.COMPOUND:25087507

subject_name: Human lactoferrin peptide 1-11

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:25087507

object_name: Bacteremia, CTCAE


subject: PUBCHEM.COMPOUND:25087507

object_name: staphylococcal infection


subject: GTOPDB:13790

subject_name: benmelstobart

object_name: esophageal squamous cell carcinoma


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: UMLS:C4550007

subject_name: UV1 vaccine

object_name: Mesothelioma


subject: UMLS:C4550007

object_name: mesothelial neoplasm


subject: UMLS:C4550007

object_name: malignant mesothelioma


subject: UMLS:C4550007

object_name: pleural mesothelioma


subject: UMLS:C4550007

object_name: lung; mesothelioma


subject: UMLS:C4550007

object_name: malignant pleural mesothelioma


subject: UMLS:C4550007

object_name: lung cancer


subject: UMLS:C4550007

object_name: lung carcinoma


subject: UMLS:C4550007

object_name: cancer


subject: UMLS:C4550007

object_name: neoplasm


subject: UNII:KWM30LC1JM

object_name: type 2 diabetes mellitus


subject: UNII:KWM30LC1JM

object_name: Diabetes


subject: UNII:KWM30LC1JM

object_name: diabetes mellitus


subject: UMLS:C2930769


subject: UMLS:C2930769


subject: UMLS:C2930769


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Advanced prostate cancer


subject: CHEBI:167574

subject_name: Semaglutide

object_name: interstitial lung disease


subject: CHEBI:167574

object_name: chronic obstructive pulmonary disease


subject: CHEBI:167574

object_name: pulmonary sarcoidosis


subject: CHEBI:167574

object_name: pulmonary hypertension


subject: CHEBI:167574

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: nephrogenic diabetes insipidus


subject: CHEBI:135973

subject_name: Miacalcic


subject: UNII:DF35I47HCM

subject_name: CALCITONIN


subject: CHEBI:192614

subject_name: Homosildenafil


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEMBL.COMPOUND:CHEMBL2108628

subject_name: PACLITAXEL POLIGLUMEX

object_name: fallopian tube carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: fallopian tube cancer


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: peritoneum cancer


subject: CHEBI:135089

subject_name: Propacetamol

object_name: Arrhythmia


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C4287773

object_name: colorectal cancer


subject: CHEBI:32865

subject_name: L-prolyl group

object_name: Albuminuria


subject: CHEBI:32865

object_name: type 1 diabetes mellitus


subject: CHEBI:32865

object_name: kidney disorder


subject: CHEBI:32865

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:135409347

subject_name: L-Alanosine

object_name: lung cancer


subject: PUBCHEM.COMPOUND:135409347

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:135409347

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:135409347

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:135409347

object_name: sarcoma


subject: PUBCHEM.COMPOUND:135409347

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:135409347

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:135409347

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:135409347

object_name: malignant mesothelioma


subject: UNII:2CNI71214Y

subject_name: Alanosine


subject: UNII:2CNI71214Y


subject: UNII:2CNI71214Y


subject: UNII:2CNI71214Y


subject: UNII:2CNI71214Y


subject: UNII:2CNI71214Y


subject: UNII:2CNI71214Y


subject: UNII:2CNI71214Y


subject: UNII:2CNI71214Y


subject: PUBCHEM.COMPOUND:135516356

subject_name: D,L-Alanosine


subject: PUBCHEM.COMPOUND:135516356


subject: PUBCHEM.COMPOUND:135516356


subject: PUBCHEM.COMPOUND:135516356


subject: PUBCHEM.COMPOUND:135516356


subject: PUBCHEM.COMPOUND:135516356


subject: PUBCHEM.COMPOUND:135516356


subject: PUBCHEM.COMPOUND:135516356


subject: PUBCHEM.COMPOUND:135516356


subject: UMLS:C0051066

subject_name: alanosine


subject: UMLS:C0051066


subject: UMLS:C0051066


subject: UMLS:C0051066


subject: UMLS:C0051066


subject: UMLS:C0051066


subject: UMLS:C0051066


subject: UMLS:C0051066


subject: UMLS:C0051066


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: non-Hodgkin lymphoma


subject: CHEBI:64317

subject_name: Isoprenaline

object_name: coronary artery disorder


subject: CHEBI:137064

subject_name: Galunisertib

object_name: childhood neoplasm


subject: CHEBI:137064

object_name: neoplastic syndrome


subject: CHEBI:137064

object_name: cancer or benign tumor


subject: UMLS:C1136845

object_name: ductal breast carcinoma in situ


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: CHEBI:17439

subject_name: Cyanocobalamin

object_name: fibromyalgia


subject: UMLS:C2370023

subject_name: Galantamine Hydrobromide ER

object_name: schizophrenia


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: hypoplastic left heart syndrome


subject: CHEBI:192614

object_name: tricuspid atresia


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: cervical squamous cell carcinoma


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:91400

subject_name: Afatinib

object_name: Solid Neoplasm


subject: UMLS:C4549005

object_name: EXCESS LMW-DNA


subject: UMLS:C5965150

subject_name: Boric Acid, vaginal suppository

object_name: vulvovaginal candidiasis


subject: CHEBI:64312

subject_name: Memantine

object_name: Parkinson disease


subject: CHEBI:27732

subject_name: Caffeine

object_name: familial partial lipodystrophy


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Muscle Invasive Bladder Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297568


subject: UMLS:C4329325

subject_name: Anti-GITR Agonistic Monoclonal Antibody BMS-986156


subject: CHEBI:90683

subject_name: Talmapimod

object_name: rheumatoid arthritis


subject: CHEBI:23359

subject_name: colchicine

object_name: platelet aggregation, spontaneous


subject: PR:000012673

subject_name: 14 kDa phosphohistidine phosphatase

object_name: systemic inflammatory response syndrome


subject: PR:000012673

object_name: Shock


subject: PR:000023548

subject_name: phosphotriesterase homology protein


subject: PR:000023548


subject: CHEBI:31781

subject_name: Lopinavir

object_name: primary biliary cholangitis


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: UMLS:C5453736

subject_name: Dexamethasone PO


subject: CHEBI:72296

subject_name: Apixaban

object_name: LVAD (left ventricular assist device) thrombosis


subject: CHEBI:7565

subject_name: Nifedipine

object_name: atrial fibrillation


subject: CHEBI:7565

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:7565

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:9434

subject_name: Telmisartan


subject: CHEBI:9434


subject: CHEBI:9434


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: adult oligodendroglioma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C1742400

object_name: tinea unguium


subject: UMLS:C2984513

subject_name: 4-Peptide Melanoma Vaccine

object_name: melanoma


subject: UMLS:C0722264

subject_name: Ontak


subject: CHEBI:5523

subject_name: Goserelin

object_name: estrogen-receptor positive breast cancer


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Anticoagulants and Bleeding Disorders


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: PUBCHEM.COMPOUND:5245480

object_name: psoriasis


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:33380

subject_name: thulium atom


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:55460

subject_name: trimellityl group


subject: UMLS:C3166394

subject_name: Tm antigen


subject: PR:000002105

subject_name: thrombomodulin


subject: CHEBI:9352

subject_name: Sulindac

object_name: unspecified adult solid tumor, protocol specific


subject: DRUGBANK:DB18648

object_name: Acute graft versus host disease in intestine


subject: DRUGBANK:DB18648

object_name: Steroid Refractory Graft Versus Host Disease


subject: PUBCHEM.COMPOUND:11546664

subject_name: revamilast

object_name: asthma


subject: UNII:30LE65637T

subject_name: Revamilast


subject: PUBCHEM.COMPOUND:23724990

subject_name: Phytate Sodium

object_name: iron deficiency anemia


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Overweight


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: PUBCHEM.COMPOUND:425400

subject_name: alpha-Tocopherol succinate


subject: CHEBI:230570


subject: CHEBI:22470

subject_name: alpha-tocopherol


subject: CHEBI:22470

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:22470

object_name: obesity


subject: CHEBI:22470

object_name: Obesity, CTCAE


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C1704263

subject_name: green tea extract


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: CHEBI:62466

subject_name: Prolycopene


subject: CHEBI:62466


subject: CHEBI:62466


subject: CHEBI:62466


subject: CHEBI:15948

subject_name: Lycopene


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:7852

subject_name: Oxycodone

object_name: opioid abuse


subject: CHEBI:7852

object_name: Opioid Misuse


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: EXCESS LMW-DNA


subject: UMLS:C0041044


subject: PUBCHEM.COMPOUND:8230

subject_name: Argipressin

object_name: septic shock


subject: PUBCHEM.COMPOUND:8230

object_name: Sepsis


subject: PUBCHEM.COMPOUND:8230

object_name: Sepsis, CTCAE


subject: UMLS:C1527128

subject_name: Recombinant Vasopressin


subject: UMLS:C1527128


subject: UMLS:C1527128


subject: UMLS:C0003779

subject_name: argipressin


subject: UMLS:C0003779


subject: UMLS:C0003779


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:53477739


subject: UMLS:C1959568

subject_name: Fumaric Acid Esters

object_name: cutaneous lupus erythematosus


subject: DRUGBANK:DB08937

object_name: Metastatic malignant neoplasm to liver


subject: DRUGBANK:DB08937

object_name: colon carcinoma


subject: DRUGBANK:DB08937

object_name: colon cancer


subject: CHEBI:90876

subject_name: Lonsurf


subject: CHEBI:90876


subject: CHEBI:90876


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:521372

object_name: inflammatory bowel disease


subject: UMLS:C5417850

subject_name: Anti-EGFR/CD16A Bispecific Antibody AFM24

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: obstructive lung disease


subject: CHEMBL.COMPOUND:CHEMBL2134724

object_name: Airway Remodeling


subject: CHEMBL.COMPOUND:CHEMBL2134724

object_name: parasympathetic nervous system disorder


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: CHEBI:5957


subject: CHEBI:5957


subject: PUBCHEM.COMPOUND:3021749


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: UNII:J697UZ2A9J


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:657309


subject: CHEBI:2549

subject_name: Albuterol


subject: CHEBI:2549


subject: CHEBI:2549


subject: UMLS:C3274746

subject_name: PVS-RIPO

object_name: invasive breast carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: High-Risk Cancer


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J

object_name: Marinesco-Sjogren syndrome


subject: UNII:PQX0D8J21J

object_name: Microsatellite Stable


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Recurrent Uterine Sarcoma


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: clear cell sarcoma


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Pregnancy Outcome


subject: CHEBI:3077

object_name: congenital alveolar dysplasia


subject: CHEBI:3077

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: fallopian tube carcinoma


subject: CHEBI:63605

object_name: fallopian tube cancer


subject: CHEBI:63605

object_name: Ovarian cancer stage III


subject: CHEBI:63605

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:63605

object_name: Ovarian cancer stage IV


subject: CHEBI:63605

object_name: Recurrent ovarian cancer


subject: CHEBI:63605

object_name: female reproductive organ cancer


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Infection


subject: CHEBI:168396

object_name: infectious disease


subject: CHEBI:168396

object_name: Adverse Event Associated with Infection


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:3638

subject_name: Chloroquine

object_name: small cell lung carcinoma


subject: UNII:1D2T74921W

subject_name: NAFAMOSTAT MESYLATE


subject: UNII:1D2T74921W

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:9868041


subject: PUBCHEM.COMPOUND:9868041


subject: CHEBI:135466

subject_name: Nafamostat


subject: UMLS:C0207682

subject_name: nafamostat mesilate


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:31709

subject_name: Iohexol

object_name: Malignant Solid Neoplasm


subject: UMLS:C3490133

object_name: Neck Carcinoma


subject: UMLS:C3490133

object_name: head and neck neoplasm


subject: UMLS:C3490133

object_name: head and neck cancer


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: cataract


subject: PUBCHEM.COMPOUND:22227703

object_name: Cataract, CTCAE 3.0


subject: PUBCHEM.COMPOUND:22227703

object_name: Cataract, CTCAE 5.0


subject: PUBCHEM.COMPOUND:22227703

object_name: cataract on exam (physical finding)


subject: CHEBI:50848

subject_name: Loteprednol


subject: CHEBI:50848


subject: CHEBI:50848


subject: CHEBI:50848


subject: UNII:47RRR83SK7

subject_name: [OBSOLETE] interferon alfa-2a

object_name: renal cell adenocarcinoma


subject: UNII:47RRR83SK7

object_name: kidney cancer


subject: UNII:47RRR83SK7

object_name: renal cell carcinoma


subject: UNII:47RRR83SK7

object_name: childhood kidney cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108508

subject_name: INTERFERON ALFA-2A


subject: CHEMBL.COMPOUND:CHEMBL2108508


subject: CHEMBL.COMPOUND:CHEMBL2108508


subject: CHEMBL.COMPOUND:CHEMBL2108508


subject: UMLS:C0021734

subject_name: Roferon-A


subject: UMLS:C0021734


subject: UMLS:C0021734


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UNII:DNZ11VPY7Q

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:DNZ11VPY7Q

object_name: myelofibrosis


subject: UNII:DNZ11VPY7Q

object_name: Myelodysplasia


subject: UNII:DNZ11VPY7Q

object_name: Myelodysplasia, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: AIDS-Related Diffuse Large B-cell Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Burkitt lymphoma associated with AIDS


subject: UNII:PVI5M0M1GW

object_name: AIDS-Related Plasmablastic Lymphoma


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: AIDS-Related Primary Effusion Lymphoma


subject: UNII:PVI5M0M1GW

object_name: HIV infection


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:2611

subject_name: Alprazolam

object_name: anxiety


subject: CHEBI:2611

object_name: Anxiety symptoms


subject: CHEBI:2611

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:2611

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Advanced cancer


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: CHEBI:9150

subject_name: Simvastatin

object_name: biliary tract cancer


subject: CHEBI:9150


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: blindness


subject: UNII:ZL1R02VT79

object_name: Impaired Vision


subject: UMLS:C3892863

subject_name: filgrastim-sndz

object_name: Plasma cell myeloma refractory


subject: UMLS:C3892863

object_name: Plasma cell myeloma recurrent


subject: MESH:D008458

subject_name: Measles Vaccine

object_name: Morbidity


subject: MESH:D008458

object_name: mortality


subject: UMLS:C5240001

subject_name: Vaccine product containing only Measles morbillivirus antigen (medicinal product)


subject: UMLS:C5240001


subject: UMLS:C1831647

object_name: stomatitis


subject: CHEBI:47898

subject_name: Epirubicin

object_name: skin melanoma


subject: CHEBI:9352

subject_name: Sulindac


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: myotonic dystrophy type 1


subject: PUBCHEM.COMPOUND:435949

object_name: myotonic dystrophy


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:33330

subject_name: scandium atom


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: GTOPDB:13624

subject_name: inclisiran

object_name: Plaque, Atherosclerotic


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: age


subject: MESH:C000628612

object_name: Plexosarcoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: lung disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: voice disorders


subject: CHEBI:6375

object_name: Dysphonia


subject: CHEBI:6375

object_name: Hoarse voice


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: Childhood Breast Carcinoma


subject: UMLS:C4289970

object_name: breast carcinoma


subject: UMLS:C4289970

object_name: breast cancer


subject: UMLS:C4289970

object_name: triple-negative breast carcinoma


subject: UMLS:C4289970

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5666876

subject_name: BRAF V600E Inhibitor HLX208

object_name: colorectal cancer


subject: UMLS:C5666876

object_name: colorectal carcinoma


subject: CHEBI:50663

subject_name: Zanamivir

object_name: Influenza A virus infection


subject: CHEBI:50663

object_name: Influenza B virus infection


subject: PUBCHEM.COMPOUND:66621102

object_name: Cirrhosis


subject: PUBCHEM.COMPOUND:66621102

object_name: liver cirrhosis


subject: CHEBI:85089

subject_name: Ledipasvir


subject: CHEBI:85089


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:85083


subject: PUBCHEM.COMPOUND:11422859

object_name: High Risk Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: stroke due to basilar artery occlusion


subject: PUBCHEM.COMPOUND:54675783

object_name: basilar artery occlusion


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Familial hypophosphatemia


subject: UMLS:C1145201

object_name: hyperparathyroidism


subject: UMLS:C1145201

object_name: Hyperparathyroidism, CTCAE


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: UMLS:C5204716

object_name: systemic sclerosis


subject: UMLS:C5204716

object_name: diffuse scleroderma


subject: CHEBI:50859

subject_name: Bexarotene

object_name: psoriasis


subject: CHEBI:6801

subject_name: Metformin

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: aphthous stomatitis


subject: CHEBI:27470

object_name: Oral ulcer


subject: PUBCHEM.COMPOUND:2269

object_name: Puerperal endometritis


subject: PUBCHEM.COMPOUND:2269

object_name: Meconium staining


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UMLS:C5960021

subject_name: STING Agonist PF-07820435

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5960021

object_name: urothelial carcinoma


subject: UMLS:C5960021

object_name: transitional cell carcinoma


subject: UMLS:C5960021

object_name: colorectal carcinoma


subject: UMLS:C5960021

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5960021

object_name: clear cell renal carcinoma


subject: UMLS:C5960021

object_name: renal cell adenocarcinoma


subject: UMLS:C5960021

object_name: renal cell carcinoma


subject: UMLS:C5960021

object_name: ovarian cancer


subject: UMLS:C5960021

object_name: ovarian carcinoma


subject: UMLS:C5960021

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5960021

object_name: neoplasm


subject: UMLS:C5960021

object_name: melanoma


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: UNII:LZZ0IC2EWP


subject: DRUGBANK:DB16444

object_name: Coronavinae infectious disease


subject: CHEBI:36796

subject_name: duloxetine

object_name: Acute Pain


subject: CHEBI:36796

object_name: arthropathy


subject: CHEBI:36796

object_name: Abnormal joint morphology


subject: CHEBI:50858

subject_name: corticosteroid

object_name: preterm premature rupture of the membranes


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Gene Amplification Abnormality


subject: CHEBI:52172

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:52172

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:52172

object_name: metastatic melanoma


subject: CHEBI:52172

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:52172

object_name: malignant melanoma of skin TNM staging primary tumor (T) T0


subject: PUBCHEM.COMPOUND:25051804

subject_name: Azvudine

object_name: COVID-19 respiratory infection


subject: UNII:IJ2XP0ID0K

subject_name: azvudine


subject: CHEBI:64356

subject_name: Pregabalin

object_name: adult hepatocellular carcinoma


subject: CHEBI:64356

object_name: liver cancer


subject: CHEBI:64356

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:64356

object_name: liver carcinoma


subject: UMLS:C1815260

subject_name: Advate

object_name: severe hemophilia A


subject: CHEBI:4875

subject_name: Etanercept

object_name: Inflammation


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: fibrosis


subject: UNII:N824AOU5XV

subject_name: Pegvisomant


subject: CHEBI:6427

subject_name: Leuprolide

object_name: type 2 diabetes mellitus


subject: CHEBI:6427

object_name: Insulin resistance


subject: CHEBI:27732

subject_name: Caffeine

object_name: Supraventricular tachycardia


subject: CHEBI:27732

object_name: atrial fibrillation


subject: CHEBI:27732

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:27732

object_name: Atrial Fibrillation, CTCAE


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: Hyperketonemia


subject: UNII:X587FW0372


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Smith-Lemli-Opitz syndrome


subject: DRUGBANK:DB14317

subject_name: Pomegranate

object_name: Heart Disease Risk Factors


subject: UMLS:C1961993

subject_name: pomegranate extract


subject: UMLS:C5446898

subject_name: LSD1 Inhibitor TAS1440

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5446898

object_name: acute myeloid leukemia


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: Acute Pain


subject: CHEBI:6539

subject_name: Lorazepam


subject: UMLS:C5907956

subject_name: Autologous dnTGF-BRII-armored Anti-GPC3 CAR T-cells AZD5851


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Androgen excess


subject: GTOPDB:5962

subject_name: dovitinib

object_name: prostate carcinoma


subject: GTOPDB:5962

object_name: prostate cancer


subject: UMLS:C1879711

subject_name: AMG 102


subject: UMLS:C1879711


subject: UMLS:C1879711

object_name: cancer


subject: UMLS:C1879711

object_name: neoplasm


subject: UMLS:C1879711

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3493731

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:167997

subject_name: Cellulose, microcrystalline

object_name: Sedation


subject: CHEBI:167997

object_name: Sedated


subject: CHEBI:167997

object_name: Surgical procedure finding


subject: CHEBI:62968

subject_name: Microcrystalline cellulose


subject: CHEBI:62968


subject: CHEBI:62968


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:9674

subject_name: Triazolam


subject: CHEBI:9674


subject: CHEBI:9674


subject: PUBCHEM.COMPOUND:11281445

subject_name: NAVARIXIN

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:11281445

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:168310632

subject_name: Navarixin


subject: PUBCHEM.COMPOUND:168310632


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: ST-elevation myocardial infarction


subject: CHEBI:16480

object_name: ST Elevation Myocardial Infarction


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:131769963

object_name: glioma susceptibility 1


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:36704

subject_name: Imiquimod

object_name: psoriasis


subject: UNII:GK1LYB375A

subject_name: Tralokinumab

object_name: alopecia areata


subject: UNII:GK1LYB375A

object_name: alopecia


subject: CHEBI:9434

subject_name: Telmisartan

object_name: inherited lipid metabolism disorder


subject: CHEBI:9434

object_name: Dyslipidemia


subject: CHEBI:8499

subject_name: Propranolol

object_name: tuberous sclerosis


subject: CHEBI:8499

object_name: situs inversus


subject: CHEBI:27375

subject_name: Vinblastine

object_name: Hyperleukocytosis


subject: CHEBI:27375

object_name: acute myeloid leukemia


subject: CHEBI:26710

object_name: Achalasia


subject: UNII:V5Y646AW8S

object_name: hepatitis C


subject: UNII:V5Y646AW8S

object_name: chronic hepatitis C virus infection


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:305790

subject_name: thyroxine

object_name: hypothyroidism


subject: CHEBI:305790

object_name: Hypothyroidism, CTCAE


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin

object_name: cervical cancer


subject: UNII:PUE0TO3XDR

object_name: cervical carcinoma


subject: UNII:PUE0TO3XDR

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:PUE0TO3XDR

object_name: myeloproliferative neoplasm


subject: UNII:PUE0TO3XDR

object_name: hepatic veno-occlusive disease


subject: UNII:PUE0TO3XDR

object_name: Venous occlusion


subject: UNII:PUE0TO3XDR

object_name: Myelodysplasia


subject: UNII:PUE0TO3XDR

object_name: leukemia


subject: UNII:PUE0TO3XDR

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:86567101

subject_name: TREAMID


subject: PUBCHEM.COMPOUND:86567101

object_name: pulmonary fibrosis


subject: UNII:NPJ3B3A39Y


subject: UNII:NPJ3B3A39Y


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Binge eating behavior


subject: UMLS:C1099192


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: atopic eczema


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:16389

subject_name: Ubiquinone Q2

object_name: Myocardial injury


subject: PUBCHEM.COMPOUND:119058

subject_name: Ubiquinones


subject: CHEBI:46245

subject_name: Ubidecarenone


subject: CHEBI:6931

subject_name: Midazolam

object_name: liver disorder


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: mental disorder


subject: CHEBI:31236

object_name: psychiatric disorder


subject: CHEBI:49956

subject_name: Xenon

object_name: interstitial lung disease


subject: CHEBI:49956

object_name: lung cancer


subject: CHEBI:49956

object_name: lung neoplasm


subject: CHEBI:49956

object_name: lung carcinoma


subject: CHEBI:49956

object_name: recurrent pneumonia


subject: CHEBI:49956

object_name: Lung Infection, CTCAE


subject: CHEBI:49956

object_name: chronic obstructive pulmonary disease


subject: CHEBI:49956

object_name: pulmonary hypertension


subject: CHEBI:49956

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:49956

object_name: Dysplasia of lung


subject: CHEBI:49956

object_name: Hay fever


subject: CHEBI:49956

object_name: pulmonary embolism


subject: CHEBI:49956

object_name: pulmonary fibrosis


subject: CHEBI:49956

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:49956

object_name: bronchiectasis


subject: CHEBI:49956

object_name: Mesothelioma


subject: CHEBI:49956

object_name: mesothelial neoplasm


subject: CHEBI:49956

object_name: malignant mesothelioma


subject: CHEBI:49956

object_name: cold; virus


subject: CHEBI:49956

object_name: asbestosis


subject: CHEBI:49956

object_name: emphysema


subject: CHEBI:49956

object_name: asthma


subject: CHEBI:53315

subject_name: poly[9,9-bis((6'-N,N,N-trimethylammonium)hexyl)fluorenylene phenylene dibromide] macromolecule

object_name: interstitial lung disease


subject: CHEBI:53315

object_name: lung cancer


subject: CHEBI:53315

object_name: lung neoplasm


subject: CHEBI:53315

object_name: lung carcinoma


subject: CHEBI:53315

object_name: recurrent pneumonia


subject: CHEBI:53315

object_name: Lung Infection, CTCAE


subject: CHEBI:53315

object_name: chronic obstructive pulmonary disease


subject: CHEBI:53315

object_name: pulmonary hypertension


subject: CHEBI:53315

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:53315

object_name: obstructive sleep apnea syndrome


subject: CHEBI:53315

object_name: Dysplasia of lung


subject: CHEBI:53315

object_name: Hay fever


subject: CHEBI:53315

object_name: pulmonary embolism


subject: CHEBI:53315

object_name: pulmonary fibrosis


subject: CHEBI:53315

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:53315

object_name: bronchiectasis


subject: CHEBI:53315

object_name: Mesothelioma


subject: CHEBI:53315

object_name: mesothelial neoplasm


subject: CHEBI:53315

object_name: malignant mesothelioma


subject: CHEBI:53315

object_name: cold; virus


subject: CHEBI:53315

object_name: asbestosis


subject: CHEBI:53315

object_name: emphysema


subject: CHEBI:53315

object_name: asthma


subject: CHEBI:60588

subject_name: poly[9,9-bis((6'-N,N,N-trimethylammonium)hexyl)fluorenylene phenylene dibromide] polymer

object_name: interstitial lung disease


subject: CHEBI:60588

object_name: lung cancer


subject: CHEBI:60588

object_name: lung neoplasm


subject: CHEBI:60588

object_name: lung carcinoma


subject: CHEBI:60588

object_name: recurrent pneumonia


subject: CHEBI:60588

object_name: Lung Infection, CTCAE


subject: CHEBI:60588

object_name: chronic obstructive pulmonary disease


subject: CHEBI:60588

object_name: pulmonary hypertension


subject: CHEBI:60588

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:60588

object_name: obstructive sleep apnea syndrome


subject: CHEBI:60588

object_name: Dysplasia of lung


subject: CHEBI:60588

object_name: Hay fever


subject: CHEBI:60588

object_name: pulmonary embolism


subject: CHEBI:60588

object_name: pulmonary fibrosis


subject: CHEBI:60588

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:60588

object_name: bronchiectasis


subject: CHEBI:60588

object_name: Mesothelioma


subject: CHEBI:60588

object_name: mesothelial neoplasm


subject: CHEBI:60588

object_name: malignant mesothelioma


subject: CHEBI:60588

object_name: cold; virus


subject: CHEBI:60588

object_name: asbestosis


subject: CHEBI:60588

object_name: emphysema


subject: CHEBI:60588

object_name: asthma


subject: CHEBI:31980

subject_name: Perflutren

object_name: interstitial lung disease


subject: CHEBI:31980

object_name: lung cancer


subject: CHEBI:31980

object_name: lung neoplasm


subject: CHEBI:31980

object_name: lung carcinoma


subject: CHEBI:31980

object_name: recurrent pneumonia


subject: CHEBI:31980

object_name: Lung Infection, CTCAE


subject: CHEBI:31980

object_name: chronic obstructive pulmonary disease


subject: CHEBI:31980

object_name: pulmonary hypertension


subject: CHEBI:31980

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:31980

object_name: obstructive sleep apnea syndrome


subject: CHEBI:31980

object_name: Dysplasia of lung


subject: CHEBI:31980

object_name: Hay fever


subject: CHEBI:31980

object_name: pulmonary embolism


subject: CHEBI:31980

object_name: pulmonary fibrosis


subject: CHEBI:31980

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:31980

object_name: bronchiectasis


subject: CHEBI:31980

object_name: Mesothelioma


subject: CHEBI:31980

object_name: mesothelial neoplasm


subject: CHEBI:31980

object_name: malignant mesothelioma


subject: CHEBI:31980

object_name: cold; virus


subject: CHEBI:31980

object_name: asbestosis


subject: CHEBI:31980

object_name: emphysema


subject: CHEBI:31980

object_name: asthma


subject: UniProtKB:P35763

subject_name: PERF_RAT Perforin-1 (sprot)

object_name: interstitial lung disease


subject: UniProtKB:P35763

object_name: lung cancer


subject: UniProtKB:P35763

object_name: lung neoplasm


subject: UniProtKB:P35763

object_name: lung carcinoma


subject: UniProtKB:P35763

object_name: recurrent pneumonia


subject: UniProtKB:P35763

object_name: Lung Infection, CTCAE


subject: UniProtKB:P35763

object_name: chronic obstructive pulmonary disease


subject: UniProtKB:P35763

object_name: pulmonary hypertension


subject: UniProtKB:P35763

object_name: Pulmonary Hypertension, CTCAE


subject: UniProtKB:P35763

object_name: obstructive sleep apnea syndrome


subject: UniProtKB:P35763

object_name: Dysplasia of lung


subject: UniProtKB:P35763

object_name: Hay fever


subject: UniProtKB:P35763

object_name: pulmonary embolism


subject: UniProtKB:P35763

object_name: pulmonary fibrosis


subject: UniProtKB:P35763

object_name: Pulmonary Fibrosis, CTCAE


subject: UniProtKB:P35763

object_name: bronchiectasis


subject: UniProtKB:P35763

object_name: Mesothelioma


subject: UniProtKB:P35763

object_name: mesothelial neoplasm


subject: UniProtKB:P35763

object_name: malignant mesothelioma


subject: UniProtKB:P35763

object_name: cold; virus


subject: UniProtKB:P35763

object_name: asbestosis


subject: UniProtKB:P35763

object_name: emphysema


subject: UniProtKB:P35763

object_name: asthma


subject: PR:000003466

object_name: interstitial lung disease


subject: PR:000003466

object_name: lung cancer


subject: PR:000003466

object_name: lung neoplasm


subject: PR:000003466

object_name: lung carcinoma


subject: PR:000003466

object_name: recurrent pneumonia


subject: PR:000003466

object_name: Lung Infection, CTCAE


subject: PR:000003466

object_name: chronic obstructive pulmonary disease


subject: PR:000003466

object_name: pulmonary hypertension


subject: PR:000003466

object_name: Pulmonary Hypertension, CTCAE


subject: PR:000003466

object_name: obstructive sleep apnea syndrome


subject: PR:000003466

object_name: Dysplasia of lung


subject: PR:000003466

object_name: Hay fever


subject: PR:000003466

object_name: pulmonary embolism


subject: PR:000003466

object_name: pulmonary fibrosis


subject: PR:000003466

object_name: Pulmonary Fibrosis, CTCAE


subject: PR:000003466

object_name: bronchiectasis


subject: PR:000003466

object_name: Mesothelioma


subject: PR:000003466

object_name: mesothelial neoplasm


subject: PR:000003466

object_name: malignant mesothelioma


subject: PR:000003466

object_name: cold; virus


subject: PR:000003466

object_name: asbestosis


subject: PR:000003466

object_name: emphysema


subject: PR:000003466

object_name: asthma


subject: CHEBI:30496

subject_name: Sulfur hexafluoride

object_name: interstitial lung disease


subject: CHEBI:30496

object_name: lung cancer


subject: CHEBI:30496

object_name: lung neoplasm


subject: CHEBI:30496

object_name: lung carcinoma


subject: CHEBI:30496

object_name: recurrent pneumonia


subject: CHEBI:30496

object_name: Lung Infection, CTCAE


subject: CHEBI:30496

object_name: chronic obstructive pulmonary disease


subject: CHEBI:30496

object_name: pulmonary hypertension


subject: CHEBI:30496

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:30496

object_name: obstructive sleep apnea syndrome


subject: CHEBI:30496

object_name: Dysplasia of lung


subject: CHEBI:30496

object_name: Hay fever


subject: CHEBI:30496

object_name: pulmonary embolism


subject: CHEBI:30496

object_name: pulmonary fibrosis


subject: CHEBI:30496

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:30496

object_name: cystic fibrosis


subject: CHEBI:30496

object_name: bronchiectasis


subject: CHEBI:30496

object_name: Mesothelioma


subject: CHEBI:30496

object_name: mesothelial neoplasm


subject: CHEBI:30496

object_name: malignant mesothelioma


subject: CHEBI:30496

object_name: cold; virus


subject: CHEBI:30496

object_name: asbestosis


subject: CHEBI:30496

object_name: emphysema


subject: CHEBI:30496

object_name: asthma


subject: DRUGBANK:DB16452

object_name: Still Disease


subject: DRUGBANK:DB16452

object_name: juvenile idiopathic arthritis


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: ventilator-associated pneumonia


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: PUBCHEM.COMPOUND:58641927

subject_name: Ulixertinib

object_name: ERK Family Gene Mutation


subject: PUBCHEM.COMPOUND:58641927

object_name: MEK Family Gene Mutation


subject: PUBCHEM.COMPOUND:58641927

object_name: BRAF gene mutation


subject: PUBCHEM.COMPOUND:58641927

object_name: H-ras gene mutation


subject: PUBCHEM.COMPOUND:58641927

object_name: N-ras gene mutation


subject: PUBCHEM.COMPOUND:58641927

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:58641927

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:58641927

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: KRAS Activating Mutation


subject: PUBCHEM.COMPOUND:58641927

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:58641927

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:58641927

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:58641927

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:58641927

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:58641927

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:58641927

object_name: small intestine cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: small intestine carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:58641927

object_name: adult glioblastoma


subject: UMLS:C4287812

subject_name: ulixertinib

object_name: ERK Family Gene Mutation


subject: UMLS:C4287812

object_name: MEK Family Gene Mutation


subject: UMLS:C4287812

object_name: BRAF gene mutation


subject: UMLS:C4287812

object_name: H-ras gene mutation


subject: UMLS:C4287812

object_name: N-ras gene mutation


subject: UMLS:C4287812

object_name: thyroid tumor


subject: UMLS:C4287812

object_name: thyroid cancer


subject: UMLS:C4287812

object_name: bladder tumor


subject: UMLS:C4287812

object_name: urinary bladder cancer


subject: UMLS:C4287812

object_name: childhood bladder carcinoma


subject: UMLS:C4287812

object_name: KRAS Activating Mutation


subject: UMLS:C4287812

object_name: gastric cancer


subject: UMLS:C4287812

object_name: ovarian neoplasm


subject: UMLS:C4287812

object_name: pancreatic neoplasm


subject: UMLS:C4287812

object_name: malignant pancreatic neoplasm


subject: UMLS:C4287812

object_name: head and neck neoplasm


subject: UMLS:C4287812

object_name: head and neck cancer


subject: UMLS:C4287812

object_name: colorectal cancer


subject: UMLS:C4287812

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4287812

object_name: esophageal cancer


subject: UMLS:C4287812

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4287812

object_name: neoplasm of esophagus


subject: UMLS:C4287812

object_name: small intestine cancer


subject: UMLS:C4287812

object_name: small intestine carcinoma


subject: UMLS:C4287812

object_name: non-small cell lung carcinoma


subject: UMLS:C4287812

object_name: cholangiocarcinoma


subject: UMLS:C4287812

object_name: glioblastoma


subject: UMLS:C4287812

object_name: Childhood Glioblastoma


subject: UMLS:C4287812

object_name: adult glioblastoma


subject: UMLS:C3641862

object_name: ERK Family Gene Mutation


subject: UMLS:C3641862

object_name: MEK Family Gene Mutation


subject: UMLS:C3641862

object_name: BRAF gene mutation


subject: UMLS:C3641862

object_name: H-ras gene mutation


subject: UMLS:C3641862

object_name: N-ras gene mutation


subject: UMLS:C3641862

object_name: thyroid tumor


subject: UMLS:C3641862

object_name: thyroid gland carcinoma


subject: UMLS:C3641862

object_name: thyroid cancer


subject: UMLS:C3641862

object_name: bladder tumor


subject: UMLS:C3641862

object_name: urinary bladder carcinoma


subject: UMLS:C3641862

object_name: urinary bladder cancer


subject: UMLS:C3641862

object_name: childhood bladder carcinoma


subject: UMLS:C3641862

object_name: KRAS Activating Mutation


subject: UMLS:C3641862

object_name: Stomach cancer


subject: UMLS:C3641862

object_name: gastric cancer


subject: UMLS:C3641862

object_name: ovarian cancer


subject: UMLS:C3641862

object_name: ovarian neoplasm


subject: UMLS:C3641862

object_name: ovarian carcinoma


subject: UMLS:C3641862

object_name: pancreatic neoplasm


subject: UMLS:C3641862

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3641862

object_name: malignant pancreatic neoplasm


subject: UMLS:C3641862

object_name: Neck Carcinoma


subject: UMLS:C3641862

object_name: head and neck neoplasm


subject: UMLS:C3641862

object_name: head and neck cancer


subject: UMLS:C3641862

object_name: colorectal cancer


subject: UMLS:C3641862

object_name: colorectal carcinoma


subject: UMLS:C3641862

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3641862

object_name: carcinoma of esophagus


subject: UMLS:C3641862

object_name: esophageal cancer


subject: UMLS:C3641862

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3641862

object_name: neoplasm of esophagus


subject: UMLS:C3641862

object_name: small intestine cancer


subject: UMLS:C3641862

object_name: small intestine carcinoma


subject: UMLS:C3641862

object_name: non-small cell lung carcinoma


subject: UMLS:C3641862

object_name: liver carcinoma


subject: UMLS:C3641862

object_name: cholangiocarcinoma


subject: UMLS:C3641862

object_name: glioblastoma


subject: UMLS:C3641862

object_name: Childhood Glioblastoma


subject: UMLS:C3641862

object_name: adult glioblastoma


subject: UMLS:C3641862

object_name: melanoma


subject: CHEBI:167638

subject_name: Labetalol

object_name: Hydralazine adverse reaction


subject: CHEBI:167638

object_name: pre-eclampsia superimposed pre-existing hypertension


subject: GTOPDB:2479

subject_name: HCl

object_name: post-traumatic stress disorder


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Bone fracture


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:95341

subject_name: Baricitinib

object_name: CANDLE syndrome


subject: CHEBI:95341

object_name: Nakajo syndrome


subject: CHEBI:95341

object_name: STING-associated vasculopathy with onset in infancy


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: Deep Venous Thrombosis Related to COVID-19


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: pneumonia


subject: CHEBI:66919

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: substance withdrawal syndrome


subject: UMLS:C0358855

object_name: Agitation


subject: UMLS:C0358855

object_name: delirium


subject: UMLS:C0358855

object_name: Delirium, CTCAE


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:233364

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:233364

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:233364

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:233364

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:233364

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:233364

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:233364

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:233364

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:233364

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:233364

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:233364

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:233364

object_name: Blast Phase


subject: CHEBI:233364

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:233364

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:233364

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:233364

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:233364

object_name: chronic myelomonocytic leukemia


subject: CHEBI:233364

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:233364

object_name: thrombocytopenia


subject: CHEBI:88353

subject_name: Bryostatin 1

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:88353

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:88353

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:88353

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:88353

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:88353

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:88353

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:88353

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:88353

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:88353

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:88353

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:88353

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:88353

object_name: Blast Phase


subject: CHEBI:88353

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:88353

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:88353

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:88353

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:88353

object_name: chronic myelomonocytic leukemia


subject: CHEBI:88353

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:88353

object_name: thrombocytopenia


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: MESH:C000600413

object_name: asthma


subject: PR:000017019

subject_name: UBX domain-containing protein 11


subject: UMLS:C0914671

subject_name: CPG-ODN

object_name: glioblastoma


subject: UMLS:C0914671

object_name: Childhood Glioblastoma


subject: UMLS:C0914671

object_name: adult glioblastoma


subject: UMLS:C4045524

object_name: head and neck squamous cell carcinoma


subject: UMLS:C0393035

object_name: fallopian tube carcinoma


subject: UMLS:C0393035

object_name: fallopian tube cancer


subject: UMLS:C0393035

object_name: ovarian cancer


subject: UMLS:C0393035

object_name: ovarian neoplasm


subject: UMLS:C0393035

object_name: ovarian carcinoma


subject: UMLS:C0393035

object_name: peritoneum cancer


subject: UMLS:C0393035

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0393035

object_name: Embolism, Tumor


subject: UMLS:C0393035

object_name: Neoplasm Metastasis


subject: UMLS:C3640945

subject_name: Talacotuzumab

object_name: adult acute myeloid leukemia


subject: UMLS:C3640945

object_name: childhood acute myeloid leukemia


subject: UMLS:C3640945

object_name: acute myeloid leukemia


subject: UMLS:C3640945

object_name: Myelodysplasia


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: post-traumatic stress disorder


subject: UMLS:C3819106

object_name: concussion


subject: UMLS:C3819106

object_name: Mild Traumatic Brain Injury


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Stress urinary incontinence


subject: UMLS:C3530149

object_name: hepatitis C


subject: UMLS:C3530149

object_name: HIV infection


subject: UMLS:C1705207

subject_name: Endostar

object_name: cervical cancer


subject: UMLS:C1705207

object_name: cervical carcinoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Abortion complicated


subject: CHEBI:135117

subject_name: ftivazide

object_name: erythropoietic protoporphyria


subject: CHEBI:6030

subject_name: Isoniazid


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Acute radiation enteritis of intestine


subject: PUBCHEM.COMPOUND:46783403

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:46783403

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:46783403

object_name: cervical adenocarcinoma


subject: PUBCHEM.COMPOUND:46783403

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1699394

subject_name: Hylenex


subject: CHEBI:291342

subject_name: Desloratadine

object_name: atopy


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: childhood kidney cell carcinoma


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: autosomal dominant hypocalcemia


subject: UNII:1C6V77QF41

object_name: Hypocalcemia


subject: UNII:1C6V77QF41

object_name: Serum calcium below normal (finding)


subject: UNII:1C6V77QF41

object_name: Hypocalcemia, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: ulcerative oral mucositis due to radiation


subject: UNII:P7UV3L2H80

subject_name: levilimab

object_name: rheumatoid arthritis


subject: UMLS:C5418030


subject: CHEBI:17688

subject_name: Nicotine

object_name: sarcoidosis


subject: CHEBI:17688

object_name: sarcoidosis, susceptibility to, 1


subject: UMLS:C1174389

object_name: renal cell carcinoma


subject: CHEBI:231324

subject_name: alpelisib

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231324

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:231324

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:231324

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:231324

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: CHEBI:231324

object_name: CDKN2A-p16 Positive


subject: CHEBI:31824

subject_name: Mesna

object_name: retinoblastoma


subject: CHEBI:17905

subject_name: Coenzyme M


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: UMLS:C0699627

subject_name: Depo-Medrone


subject: UMLS:C1098514

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide


subject: CHEBI:72690

subject_name: Pomalidomide


subject: UNII:VQ7NU11KRM

object_name: biliary tract cancer


subject: UNII:VQ7NU11KRM

object_name: liver carcinoma


subject: UMLS:C1688539

object_name: Glabellar frown lines


subject: PUBCHEM.COMPOUND:56998

object_name: pulmonary tuberculosis


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: MESH:D017780

subject_name: Malaria Vaccines

object_name: Plasmodium vivax infection


subject: UMLS:C5418043

subject_name: ADC SHR-A1811

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5418043

object_name: neoplastic meningitis


subject: UMLS:C3896843

subject_name: hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301

object_name: prostate carcinoma


subject: UMLS:C3896843

object_name: prostate cancer


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: transplant; complication, rejection


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: male breast carcinoma


subject: CHEBI:17347

subject_name: Testosterone


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Hematoma, Subdural, Chronic


subject: CHEBI:39112

subject_name: Bosutinib

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:145372

subject_name: Gilteritinib


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: colonic disease


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:68534

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:68534

object_name: Carcinoma of the prostate stage III


subject: CHEBI:68534

object_name: Stage III Prostate Cancer AJCC v6


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: oral cavity squamous cell carcinoma


subject: UNII:CWG62Q1VTB

object_name: head and neck squamous cell carcinoma


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: stroke disorder


subject: CHEBI:184023

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:184023

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:184023

object_name: diabetes mellitus


subject: CHEBI:184023

object_name: Angina pectoris


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:15365

subject_name: Aspirin


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: PR:000004321


subject: PR:000004321


subject: PR:000004321


subject: CHEBI:55352

subject_name: (R)-Atenolol


subject: CHEBI:55352

object_name: myocardial infarction


subject: CHEBI:55352


subject: CHEBI:55352


subject: CHEBI:55352


subject: CHEBI:55352


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:2904


subject: CHEBI:2904


subject: CHEBI:2904


subject: CHEBI:2904


subject: CHEBI:2904


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor


subject: CHEBI:35457


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:87631


subject: CHEBI:87631


subject: CHEBI:87631


subject: CHEBI:87631


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: tuberculosis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Neuromuscular inhibition


subject: CHEBI:4466

object_name: Hypotonia


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Prostatic Cancer, Castration-Resistant


subject: UNII:ZG6U44T8SG

subject_name: INTISMERAN AUTOGENE

object_name: non-small cell lung carcinoma


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: Tuberculous uveitis


subject: CHEBI:73629

object_name: Antituberculous drug adverse reaction


subject: CHEBI:38848

subject_name: perflunafene


subject: CHEBI:38848


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PR:000001881


subject: CHEBI:23359

subject_name: colchicine

object_name: Interstitial lung fibrosis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Postoperative Complications


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: anemia


subject: UNII:3M6325NY1R

object_name: Anemia, CTCAE


subject: UNII:3M6325NY1R

object_name: Knee arthropathy


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: pulmonary hypertension


subject: CHEBI:24261

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:24261

object_name: pulmonary hypertension due to lung diseases and hypoxia


subject: CHEBI:24261

object_name: bronchopulmonary dysplasia


subject: CHEBI:24261

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:66910

subject_name: Axitinib

object_name: BRCA Gene Mutation


subject: CHEBI:66910

object_name: HER2 protein overexpression


subject: CHEBI:66910

object_name: Her2-receptor negative breast cancer


subject: CHEBI:66910

object_name: HER2 positive breast carcinoma


subject: CHEBI:66910

object_name: Childhood Breast Carcinoma


subject: CHEBI:66910

object_name: breast carcinoma


subject: CHEBI:66910

object_name: breast cancer


subject: CHEBI:66910

object_name: breast neoplasm


subject: UNII:HS813P8QPX

subject_name: bismuth subcitrate

object_name: Dysbiosis


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: Helicobacter pylori infection


subject: UMLS:C0304547


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: CHEBI:6909

subject_name: Metronidazole


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: CHEBI:33853

subject_name: phenols

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:33853

object_name: Back pain


subject: CHEBI:33853

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:15882

subject_name: Phenol


subject: CHEBI:15882


subject: CHEBI:15882


subject: CHEBI:16164

subject_name: pyrogallol


subject: CHEBI:16164


subject: CHEBI:16164


subject: CHEBI:15966

subject_name: D-Glutamic Acid

object_name: dizziness


subject: CHEBI:15966

object_name: Vertigo as late effect of cerebrovascular disease


subject: CHEBI:15966

object_name: Vertigo, CTCAE


subject: CHEBI:16015

subject_name: Glutamic acid


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:9679


subject: CHEBI:9679


subject: CHEBI:9679


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:18385


subject: UNII:P6YC3EG204

subject_name: Erythrotin


subject: UNII:P6YC3EG204


subject: UNII:P6YC3EG204


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: CHEBI:15982


subject: CHEBI:15982


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: UMLS:C3714801


subject: UMLS:C3714801


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Unresectable Adrenal Cortical Carcinoma


subject: CHEBI:72317

object_name: Metastatic Carcinoma in the Adrenal Cortex


subject: CHEBI:72317

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C5564538

subject_name: Altargo

object_name: cellulitis


subject: CHEBI:166679

subject_name: Retapamulin


subject: UNII:4MG6O8991R


subject: CHEBI:229800

subject_name: Onapristone

object_name: Childhood Breast Carcinoma


subject: CHEBI:229800

object_name: breast carcinoma


subject: CHEBI:229800

object_name: breast cancer


subject: CHEBI:64220

subject_name: monosodium glutamate

object_name: gastroparesis


subject: CHEBI:64220

object_name: Delayed gastric emptying


subject: CHEBI:16015


subject: CHEBI:16015


subject: UMLS:C0037511

subject_name: sodium glutamate


subject: UMLS:C0037511


subject: PUBCHEM.COMPOUND:167993671

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:167993671

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:167993671

object_name: lung cancer


subject: PUBCHEM.COMPOUND:167993671

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:167993671

object_name: lung carcinoma


subject: UMLS:C5854499

subject_name: CoREST Inhibitor TNG260


subject: UMLS:C5854499


subject: UMLS:C5854499


subject: UMLS:C5854499


subject: UMLS:C5854499


subject: CHEBI:15640

subject_name: Leucovorin

object_name: malignant soft tissue neoplasm


subject: CHEBI:15640

object_name: sarcoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: UNII:6XC1PAD3KF


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:60802

subject_name: ropivacaine

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: intracranial arterial disease


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2825029

object_name: obesity


subject: UMLS:C2825029

object_name: Obesity, CTCAE


subject: UNII:J57O328W4W

subject_name: Flindokalner

object_name: migraine


subject: CHEBI:34548


subject: UMLS:C1531444

subject_name: Maxipost


subject: UNII:4HA45S22ZZ

object_name: rectal carcinoma


subject: UNII:4HA45S22ZZ

object_name: rectal cancer


subject: UNII:4HA45S22ZZ

object_name: Childhood Rectal Carcinoma


subject: UNII:4HA45S22ZZ

object_name: colon carcinoma


subject: UNII:4HA45S22ZZ

object_name: colorectal cancer


subject: UNII:4HA45S22ZZ

object_name: colon cancer


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: CHEBI:67271


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: appendicitis


subject: PUBCHEM.COMPOUND:74030550

object_name: Appendicitis, CTCAE


subject: UMLS:C4288410

subject_name: Perflubutane Microbubble

object_name: vulva carcinoma


subject: UMLS:C4288410

object_name: suppressor of tumorigenicity 3


subject: UMLS:C4288410

object_name: cervical carcinoma


subject: UMLS:C4288410

object_name: vaginal carcinoma


subject: UMLS:C4288410

object_name: female reproductive organ cancer


subject: CHEBI:52172

subject_name: Nilotinib

object_name: myeloid leukemia


subject: UMLS:C1567379


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Hemoptysis


subject: PUBCHEM.COMPOUND:123134034

subject_name: Methylcobalamin

object_name: diabetic neuropathy


subject: CHEBI:28115

subject_name: Mecobalamin


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: DRUGBANK:DB17463

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17463

object_name: Adult Solid Neoplasm